Monitoring Somatic Genetic Alterations in Circulating Cell-Free DNA/RNA of Patients with “Oncogene-Addicted” Advanced Lung Adenocarcinoma: A Real-World Clinical Study
Laura Lupini(University of Ferrara), Massimo Negrini(University of Ferrara), Alessandra Fasano(University of Ferrara), Paola Guerriero(University of Ferrara), Iva Maestri(University of Ferrara), Elena Saccenti(University of Ferrara), Valentina Tagliatti(University of Ferrara), Stefano Volinia(University of Ferrara), Giovanni Lanza(University of Ferrara), Roberta Gafà(University of Ferrara), Andrea Salamone(University of Ferrara), Angelo Michilli(University of Ferrara), Lucilla D’Abundo(University of Ferrara), Roberta Roncarati(Institute of Genetic and Biomedical Research), Antonio Frassoldati(University of Ferrara), Lorenzo Belluomini(University of Ferrara), Federica Lancia(University of Ferrara), Donato Michele Cosi(University of Ferrara), Elisa Tiberi(University of Ferrara), Silvia Sabbioni(University of Ferrara), Cristian Bassi(University of Ferrara)
Cited by 5
Related Papers
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|337
Isolation and characterization of CD146+ multipotent mesenchymal stromal cells
|Experimental Hematology|2008|254
Oncogenic Role of <i>miR-483-3p</i> at the <i>IGF2/483</i> Locus
|Cancer Research|2010|213
MSC-Regulated MicroRNAs Converge on the Transcription Factor FOXP2 and Promote Breast Cancer Metastasis
|Cell stem cell|2014|178
Gut microbiota and cancer: How gut microbiota modulates activity, efficacy and toxicity of antitumoral therapy
|Critical Reviews in Oncology/Hematology|2019|164